Abstract:Objective Congenital chylothorax (CC) is an uncommon congenital disease. The objective of this study was to analyze the clinical features, treatment, and outcome of infants with CC in a Chinese tertiary medical center. Methods CC was defined as a non-traumatic pleural effusion with ≥ 80% lymphocytes detected before birth or within 28 days after birth. Clinical data were collected in CC infants discharged from June 2017 to March 2021. Results A total of 24 CC infants were discharged during the study period, accounting for 67% of congenital pleural effusions. The median gestational age at birth was 36 +4 weeks (range 29 +5 –41 weeks) and the birth weight was 3025 g (range 1850–4250 g). Twenty-one infants were diagnosed antenatally. The median gestational age at the time of diagnosis was 30 +3 weeks (range 24–36 +6 weeks). Nine infants presented with hydrops fetalis; 18 were bilateral. Prenatal interventions were performed in 13 fetuses. Nine infants (38%) had birth asphyxia. Compared with the infants without hydrops fetalis, the infants with CC and hydrops fetalis had lower Apgar scores at 1 and 5 min ( P < 0.05) and a lower gestational age at birth ( P < 0.05). Postnatally, 17 infants required continuous pleural drainage for 10 days (range 2–30 days). Analysis of the pleural effusion showed a higher cell count, lymphocyte fraction, and protein content after enteral feeding ( P < 0.05). Fifteen infants required mechanical ventilation; 9 did not require any respiratory support. Ten infants received a delayed feeding strategy and 17 received a medium-chain triglyceride (MCT) formula. Only 1 infant received octreotide therapy. Twenty-one infants survived and 3 died. The main cause of death was pulmonary dysplasia. The duration of hospital stay in survivors was 21.5 days (range 10–43) days. For infants with CC and hydrops fetalis, prenatal therapy shortened the duration of pleural drainage and the length of hospital stay ( P < 0.05). Conclusion CC is the most common cause of congenital pleural effusions. The poor prognosis is mainly associated with prematurity, hydrops fetalis, and pulmonary dysplasia. Prenatal intervention may improve the outcome of infants with hydrops fetalis.

Successful treatment of congenital chylothorax with skimmed milk and long course octreotide

Treatment of Congenital Chylothorax Using High-Dose Octreotide

Should Newborns with Refractory Chylothorax Be Tried on Higher Dose of Octreotide?

The use of high dose octreotide in management of neonatal chylothorax: Review

Effects of Somatostatin/octreotide Treatment in Neonates with Congenital Chylothorax.

Neonatal chylothorax:a report of 4 cases

Two Cases of Congenital Chylethorax: A Successful Story of Medical Management

Evaluation of Therapy and Screening for Congenital Hypothyroidism in Neonates

Effect of Minocycline Pleurodesis in Infants With Refractory Chylothorax After Palliative Surgery for Complex Congenital Heart Disease

Treatment of concomitant persistent chylothorax and superior vena cava syndrome through innominate vein-right atrial bypass

Successful oral midodrine therapy for treatment of refractory postoperative chylothorax in an infant

Efficacy of nil per oral, total parenteral nutrition, milrinone and non-suction chest tube drainage-based management for chylothorax following pediatric cardiac surgery

Parenteral Nutrition Combined with Rice Soup Can Be a Safe and Effective Intervention for Congenital Chylous Ascites.

Successful treatment of chylous ascites following abdominal surgery with medium-chain triglyceride-rich enteral nutrition and octreotide

Recurrent bilateral idiopathic chylothorax: a therapeutic challenge

Octreotide’s role in the management of post-esophagectomy chylothorax

Clinical Features and Outcomes of Congenital Chylothorax: a Single Tertiary Medical Center Experience in China

Enteral nutrition with medium-chain triglyceride compared to total parenteral nutrition in patient with chylothorax

Laparoscopic management of the congenital chylous ascites in a newborn: Case report

Postoperative Chylothorax Following Surgery for Congenital Heart Disease

Congenital duodenal obstruction in neonates: a decade’s experience from one center